Molecular spectroscopic markers of abnormal protein aggregation by Wilkosz, Natalia et al.
molecules
Review
Molecular Spectroscopic Markers of Abnormal 
Protein Aggregation
N atalia W ilkosz, M ichał Czaja, Sara Seweryn, Katarzyna Skirliń ska-N osek, M arek Szym onski, 
Ewelina Lipiec * ©  and Kam ila Sofińska
M. Smoluchowski Institute of Physics, Jagiellonian University, 30-348 Kraków, Poland;
natalia.szydlowska@uj.edu.pl (N.W.); michalandrzej.czaja@student.uj.edu.pl (M.C.); saras@poczta.onet.pl (S.S.); 
katarzyna.skirlinska@gmail.com (K.S.-N.); ufszymon@cyf-kr.edu.pl (M.S.)
* Correspondence: ewelina.lipiec@uj.edu.pl (E.L.); kamila.sofinska@uj.edu.pl (K.S.);
Tel.: +48-12-664-45-86 (E.L. & K.S.)
Academic Editor: Gavino Sanna ch eckforupdates
Received: 28 April 2020; Accepted: 25 May 2020; Published: 27 May 2020
Abstract: Abnorm al protein aggregation has been intensively studied for over 40 years and broadly 
discussed in the literature due to its significant role in neurodegenerative diseases etiology. Structural 
reorganization and conform ational changes of the secondary structure upon the aggregation determine 
aggregation pathw ays and cytotoxicity  of the aggregates, and therefore, num erous analytical 
techniques are em ployed for a deep investigation into the secondary structure of abnorm al protein 
aggregates. M olecular spectroscopies, including R am an and infrared ones, are routinely  applied 
in such studies. Recently, the nanoscale spatial resolution of tip-enhanced R am an and infrared 
nanospectroscopies, as well as the high sensitivity of the surface-enhanced Ram an spectroscopy, have 
brought new insights into our know ledge of abnorm al protein aggregation. In this review, w e order 
and sum m arize all nano- and m icro-spectroscopic m arker bands related to abnorm al aggregation. 
Each part presents the physical principles of each particular spectroscopic technique listed above 
and a concise descrip tion of all spectral m arkers detected w ith  these techniques in  the spectra of 
neurodegenerative proteins and their m odel systems. Finally, a section concerning the application of 
m ultivariate data analysis for extraction of the spectral m arker bands is included.
Keywords: abnormal protein aggregation; secondary structure; amyloids; neurodegenerative diseases; 
m ultivariate data analysis; principal com ponent analysis (PCA); hierarchical cluster analysis (HCA); 
m olecular spectroscopy; nanospectroscopy
1. Introduction
Follow ing the increase of global average life expectancy, the w orld  population has experienced 
an upsurge in  the num ber o f individuals suffering from  deadly and debilitating neurodegenerative 
d iseases, such as A lzheim er's, P arkinson 's, and H u ntington 's disorders [1- 3 ]. R ecent estim ations 
im ply that over 50 m illion people w orldwide are living w ith dementia, and the cost of treatm ent exceed 
already 1% of the global G D P [4 ]. N eurodegenerative diseases not only affect individuals and their 
fam ilies, but also pose a crippling burden on the healthcare system s. D espite intense scientific efforts 
all over the w orld , dem entia is still incurable. The neurodegenerative processes at the heart of those 
diseases are caused by an abnormal aggregation of highly cytotoxic, structurally pathological proteins 
called am yloids [1- 3]. A  detailed investigation into the secondary structures o f neurodegenerative 
proteins and m odel proteins, that undergo fibrillation processes, is crucial for an  understanding 
of the etiology of neurodegenerative diseases, w hich  w ill allow  for the developm ent of successful 
treatm ent regimes.
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A bnorm al aggregation of proteins such as |3 -am yloid, tau, a-synu clein  and polyglutam ine- 
containing proteins is know n to be related to the pathology of neurodegenerative diseases including 
A lzh eim er's d isease (A D ), Parkinson 's disease (PD) and H u ntington 's disease (H D) [5- 7]. Protein 
aggregates are toxic and lead to neuronal death in different brain regions depending on the disease [8,9 ]. 
The etiology of neurodegenerative diseases has not been explained yet. A lot of scientists w orking on 
this issue have suggested various m echanism s of protein m isfolding and their aggregation. However, 
a complete understanding of this issue still requires further research at the molecular and cellular level.
The first im portant factor that affects protein aggregation in  neurodegenerative diseases is the 
protein structure. In particular, prim ary and secondary structures are critical factors affecting the 
physical and chem ical properties of proteins/peptides and their three-dim ensional conform ation 
(tertiary structure). In the prim ary structure, the position and num ber of different characteristic 
am ino acid residues can accelerate or slow dow n the aggregation process. In general, the num ber of 
hydrophobic am ino acids in proteins is proportional to the aggregation tendency [6]. M utations are 
another factor that affects the protein structure and are considered to have an im pact on the aggregation 
process by  changing protein solubility and stability [10].
N eurodegenerative diseases are associated w ith  the occurrence of am yloid plaques, w hich  are 
specific for each disease. A D  pathogenesis is considered to be related to tau  protein. Tau protein 
in its native state has im portant physiological functions, such as m icrotubule stabilization [11,12]. 
To perform  their functions, tau  proteins m u st be phosphorylated  at a norm al, physiological level. 
The hyperphosphorylation causes the loss of their biological activity due to conform ational changes 
and abnorm al aggregation of the tau protein [13].
A m yloid p (A p) is a sm all peptide w ith  a m ass of 4 -4 .4  kD a [14]. It is the m ain com ponent of 
am yloid deposits found in A D , m ainly in the cortex, h ippocam pus, forebrain, and brain  stem  [8 ]. 
The native Ap occurs in  neurons, astrocytes, neuroblastom a cells, hepatom a cells, fibroblasts, and 
platelets [15]. Its functions are associated w ith inflam m atory and antioxidant activity. Ap also affects 
the regulation of cholesterol transport and the activation of the kinase enzym e. N ative Ap protein 
has m ainly disordered structure bu t several research reveals the presence of local regions displaying 
a secondary structure [16,17]. The relative p-sheet content increases w ith  the ongoing aggregation 
associated w ith the AD [18].
a-synuclein (a-sy n ) is associated w ith Parkinson's disease. The mass of the a-synuclein monomer 
is ca.14 kDa. The nam e "a -sy n u cle in " com es from  its synaptic and nuclear location. a-Syn  regulates 
dopamine neurotransm ission by m odulation of vesicular dopamine storage. This protein interacts with 
tubulin. It also has a molecular protective activity in the folding of SNARE (soluble N -ethylm aleim ide- 
sensitive-factor attachm ent protein receptor) proteins [19]. Native a-syn  is soluble in the cytoplasm  in 
contrast to its abnorm al aggregates, w hich form  Lew y bodies. The secondary structure of the a -syn  
aggregates is com plex and consists of p-sheet, p-turns, a-helics/disordered conform ations [20].
O ne of polyglutam ine-containing, neurodegenerative proteins is a H untington protein (Htt). 
It has a large m ass o f 350 kD a and consists of 3144 am ino acids. N ative protein is highly expressed 
in the peripheral tissues and the brain. This protein is involved in endocytosis, vesicle trafficking, 
cellular signal transduction, and m embrane recycling. In the brain, abnormally aggregated H tt protein 
dam ages cells and it is toxic, form ing pathological aggregates [21,22].
M onitoring the aggregation process w ith  spectroscopic m ethods involves tracking the changes 
in the protein secondary structure. To correctly  interpret the progress of the am yloid  aggregation 
based  on the spectroscopic data, it is necessary  to understand the course of the aggregation process 
itself. The abnorm al protein aggregation is considered to be related to protein m isfolding leading to 
the exposure of hydrophobic am ino acid residues or w ith the change of the protein net charge [8,23] . 
The exact aggregation pathway of amyloid proteins depends on the secondary structure of aggregating 
m olecules. H ow ever, the m ain principles of the am yloid  aggregation process can be sim plified to a 
three-step fibril form ation process consisting of the lag-phase, the elongation phase and the plateau 
phase (Figure 1) [8,24,25]. W ithin the lag phase, also called a nucleation phase, the soluble oligom eric
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interm ediates are formed. The elongation phase (fibril growth phase) includes the form ation of other 
"aggregation-prone" interm ediates know n as protofibrils. A  self-tem plate growth m echanism  leads to 
their rapi d growth until thh form ation of ins o lu blem atu re fibrils [8,26]. The plateau stationary phase 
is reached w hen the content of m ature fibrils is at a  constant m axim um  level. There ere also theories 
desceibing the Iragm entation of fibrils during the aggre.ation  process changing the kinetics of mature 
fibril hormation [26,27].
Figure; 1. The; schematic representation of successive species formation in amyloid aggregationprocess.
M ature am yloid fibrils, regardless of the peptide/protein they are m ade of, possess universal 
characteristic structural features. Tire m orphology of fibrils is repeesentee by a unique cross- U structure 
consisting of hydrogen-bonded p-sheets arranged perpendicularly  along the fibril axis. The fibril 
Ciameter is usually 6-13 nm and is formed Prom 2 -8  protofilaments twisted around each other [8,24,26].
The am yloid aggregation proces s and its subsequent stepe can tie follow ed w ith  vibraPional 
spectroscopy techniques. Spectra of proteins have already been  described w ell. Individual bands 
are attributed to vibrations of various chem ical groupu peesent in  the peptide chain. A m ide bands 
A  and B as w ell as am ide bands I-V II (w avenum bess in d  assigned vibrations are show n in Table 1) 
san Ite observed in the Ram an and infrared spectra of peptides and paeteins. M olecular upectroscopy 
techniques ara sensitive; to the changes of the protein secondasy structure. Eauh of the interm edtate 
species of am y lo ie  augregation, as w ell as fibrils, are represented by  a  different ratio of individual 
secondary steuciures. In general, the |3-shee- content in creasis  w ith  the progress of the aggregation 
process [28,29]. Celeg et al. i28] registered the decrease in randem  coil and/or Ue lical structure content 
(absorbance at 1660-1650  cm --1), for a-synuclein  aggregation, from  ca. 60%  in  m opom ers to 52%  in 
oligom ers and 27% in fibrils w hile sha p-sheet contribution inc reased from 8% for m oncnsersl 26% in 
oligomers up to 51% in fibrils. In this casec the /Oturn consent (at 1670 cm -1 ) w es ca. 22% for oligomers 
nne fibrilu The different ratio of secondary struclurcs for fibrils formed from various peptide variants 
is considered to be a strong; prem ise for differenl agauegution pathw ays [30- 32].
This review is devoted to the Uascription and organization of ell m olecular spectroscopic markers 
of abnorm al protein aggregation. D ue to com prehensivr presentation of the infrared, R am an TERS, 
SER S, nanoFTIR  and A FM -IR  spectral changes related to the secondary structure m odifications of 
neurodegenerative proteins and m odel peptides, researchers can easily  verify  their results, find 
an interpretation of the observed spectral changes and com pare them  w ith  results obtained so far 
for various am yloids system s w ith  all know n m olecular spectroscopic techniques. In addition, 
the usefulness of m ultivariate data analysis in extraction of spectroscopic m arkers of the am yloids 
aggregation is presented.
Table 1. Characteristic Raman and infrared bands for proteins [33,34]
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Amide Bands Wavenumber [cm-1] Assigned Vibration 1
A 3500 v(N-H)
B 3100 v(N-H)
I 1700-1600 80% v(C=O), 10% v(C-N), 10% 6(N-H)
II 1580-1480 40% v(C-N), 60% 6(N-H)
III 1300-1230 30% v(C-N), 30% 6(N-H), 10% v(CH3-C),10% 6(O=C-N), 20% other
IV 770-625 40% s(o =C-N), 60% other
V 800-640 Y(N-H)
VI 600-540 Y(C=O)
VII 200 skeletal mode
1 v—stretching, 6—bending, y—out-of-plane bending
2. Infrared Spectroscopy Studies of Abnorm al Aggregation of Proteins/Peptides
Infrared spectroscopy (IR), along w ith Ram an spectroscopy, is one of the vibration spectroscopy 
techniques. The leading phenom enon underlying IR spectroscopy is the absorption of electromagnetic 
radiation in the infrared range by molecules, exciting vibrations and oscillations of the functional groups 
occurring in  the studied analyte [35,36]. Each chem ical bond undergoes various types of vibrations 
(i.e., stretching, bending, tw isting, rocking or w agging m otions), w hose energies correspond to the IR 
region including far, m id, and near infrared. IR  spectroscopy is selective for vibrations leading to the 
change of the m olecule dipole m om ent and these vibrations are detected in  the IR  spectrum  [35,37]. 
Due to the chem ical sensitivity, as well as the susceptibility to intra- and interm olecular effects (which 
affects the vibration frequency and the bonds polarity), IR spectroscopy is very com m on in the science 
of biological system s. A lthough the IR  spectra of biom olecules are very  com plex and consist of 
several overlapping bands (resu lting in a loss of som e inform ation), they are still extrem ely useful 
for tracking structural changes of biological m olecules. For exam ple, it is possible to follow  each 
process that affects the molecule geometry. In the case of proteins, IR spectroscopy makes it possible to 
analyze m odifications in  the protein secondary structure w hich, according to Barth [35], is probably 
the most popular application of this technique. The IR spectrum of proteins or peptides contains a few 
characteristic bands carrying the inform ation about the secondary structure, know n as the am ide I 
(1700-1600 cm -1 ), amide II (~1550 cm -1 ) and amide III (1400-1200 cm -1 ) bands. The amide I region is 
especially sensitive to the structure of the protein backbone and is the most useful in neurodegenerative 
peptide aggregation research.
For studying biological system s, in addition to the transm ission FT IR  spectroscopy (Fourier 
transform  infrared spectroscopy), the attenuated total reflectance (ATR) technique seem s to be 
advantageous. In  an ATR, a sam ple is placed on a crystal w ith  a h igh refractive index. The light is 
reflected once or several tim es on the crystal-sam ple interface, w hich helps to increase the sensitivity 
allowing to m easure thin films. The evanescent w ave, perpendicularly oriented to the crystal-sam ple 
interface, arises and penetrates into the sam ple, w here it can be absorbed. D ue to this phenom enon, 
the light reaching the detector contains inform ation about the sample structure [35,38] . ATR is especially 
helpful in biological m olecules science, w here researchers are struggling w ith  sm all am ounts of the 
studied m aterial (even less than 100 ng) and low  sam ple concentrations (in the range of gM) [26].
H istorically, the interpretation of am yloid aggregate (fibril) structures based on IR  spectra w as 
confusing. According to Sarroukh et al. [26], FTIR spectroscopy has been used to study fibril structures 
since the early  70ties. H ow ever, as w as pointed out in the m entioned review, in the earliest articles 
describing the infrared spectra of fibrils, the major components of the amide I band were misinterpreted. 
The first paper which helped w ith the proper assignment of the amide I region peaks on the FTIR spectra 
of fibrils w as released in 2000 by  Bouchard et al. [39]. Tracking the insulin  aggregation process over 
tim e (at pH 2.3, 70 °C), it w as show n that the high frequency com ponent at 1690 cm -1 appears in the 
spectrum only for short incubation times and vanishes after 18 h of incubation. It became clear that the
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ca. 1690 cm - 1  amyloid IR spectrum com ponent can be assigned to structures other than fibrils w ith the 
cross-p structure present in the sample. In general, for amyloid peptide aggregation, the spectroscopic 
m arker of the aggregation process and m ature fibril form ation is the presence of a ca. 1 6 3 0  cm - 1  
strong peak in the amide I region attributed to parallel p-sheets. At the same time, the approxim ately 
5-fold w eaker peak at ca. 1695-1685 cm - 1  characteristic for antiparallel p-sheets is not present in the 
spectrum. The simultaneous occurrence of two components at ca. 1695-1685/1630-1610 cm - 1  attributed 
to antiparallel p-sheets is visible in the IR  spectrum  w hen the aggregation process is in progress, at its 
initial stages, and oligom ers are still present in the sam ple [40] . The IR  m arker spectroscopic bands of 
neurodegenerative peptide aggregation are presented in Table 2 .
The aggregation of amyloid p (Ap) peptides using IR spectroscopy has been extensively studied, 
especially  in the past tw o decades. IR  characteristic peaks occurring in  the am ide I  region for the 
major com ponent of amyloid p deposits, amyloid p 1 -4 2  [40,41] and amyloid p 1 -4 0  peptide [42- 44] have 
already been described. To better understand the Ap aggregation process, Juszczyk et al. [31] followed 
the aggregation of synthetic 11-28 fragment of the Ap peptide w ith FTIR spectroscopy. This sequence is 
considered to be responsible for Ap aggregation. The authors also investigated the aggregation of Ap 
11-28 fragments after the introduction of five different mutations (E22K, A21G, D23N, E22G and E22Q) 
in 21-23  position. The process w as studied in H F IP -D 2 O m ixtures w ith increasing w ater content.
The cytotoxicity  of neurodegenerative proteins is considered to be strongly correlated w ith  
the secondary structure of entities occurring at subsequent stages of the am yloid  aggregation 
process [8,24,28,45,46]. To confirm  stronger cytotoxicity  of oligom ers w ith  antiparallel p-sheet 
conform ation over fibrils, Sandberg et al. [32] incorporated the double-cysteine m utation into the 
am yloid p 1 -4 2  and am yloid p 1 -4 0  (called Ap 4 2 C C  and A p 4 0 C C , respectively), w hich prevents m ature 
fibril formation by stabilizing the oligomer structure w ith an additional intramolecular disulfide bridge. 
Both m utants create stable oligom eric m olecules but w ithin a different aggregation pathway. A p42CC 
oligomers/protofibrils turned out to be ca. 50 tim es m ore efficient in apoptosis induction than A p 1 -4 2  
m onom ers or m ature fibrils.
The aggregation of a-synuclein, the 140-am ino-acid  protein m ost abu ndant in  Lew y bodies 
occurring as fibrillar intraneuronal inclusions in  Parkinson 's D isease (PD ), has also been  studied 
w ith  IR  spectroscopy [28,30,47,48]. In general, infrared spectral m arkers of a-synuclein  aggregation 
are sim ilar to those found for am yloid p (see Table 2 ). A n interesting w ork concerning a-synuclein  
aggregation w as released lately by Ruggeri et al. [30]. Due to m edical evidence of m issense mutations 
in the SCN A  gene encoding a-synuclein  involvem ent in  the PD  pathogenesis, the aggregation of a 
w ild  type a-synuclein, as w ell as its variants w ith  the one am ino acid replacem ent in the protein 
sequence, has been  studied. R esults show ed that am yloid fibrils form ed by different variants of 
a-synuclein  w ere varying in the percentage ratio of secondary structure content. This w as due to 
alternative m echanism s of the aggregation pathw ay for studied protein variants. A nother recent 
w ork concerning a-synuclein aggregation describes the influence of the ionic strength on the p-sheets 
orientation in fibrils studied w ith  1D- and 2D -IR  spectroscopy [49]. 2D -IR  spectroscopy provides 
inform ation about the specific residues of interest and is sensitive to m ore ordered structures in 
general [49,50]. The p-sheet arrangem ent in fibrils turned out to be correlated w ith salt concentration 
during fibrilization. a-synuclein  aggregation in  low  ionic strength conditions (N aC l concentration 
< 25  m M ) results in parallel p-sheet orientation in  fibrils, w hile the fibrilization upon h igh salt 
concentration, including physiological conditions, contributes to the antiparallel p-sheet arrangement.
Natalello et al. [51] studied the aggregation pathway of prion peptide PrP 8 2- 14 6  characteristic for 
another neurodegenerative amyloid disease, called G erstm ann-Straussler-Scheinker syndrom e (GSS). 
The m ajor com ponents occurring in brain am yloid plaques are the PrP peptide fragm ents consisting 
of 81 -8 2  to 144-153  am ino acids. The FTIR  spectra of the 82 -1 4 6  PrP fragm ent at the initial stages 
of aggregation revealed tw o com ponents, typical for oligom ers displaying antiparallel structures: 
a low-frequency band around 1623 cm - 1  sim ultaneously with a high-frequency band around 1690 cm -1 .
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A t the final stages of aggregation, w hen the sam ple w as rich in the cross-p structure fibrils, only the 
1626 cm -1 peak w as determ ined.
Transthyretin (TTR), a biologically relevant protein occurring in hum an plasma, serves as thyroxin 
carrier, or a retinol binding m olecule. The m isfold ing or abnorm al aggregation of TTR  leads to 
am yloidosis such as senile system ic am yloidosis (SSA), fam ilial am yloid polyneuropathy (FAP), and 
fam ilial amyloid cardiom yopathy (FAC) [52]. TTR fibril form ation w as studied by Cordeiro et al. [52] 
and earlier by  Zandom eneghi et al. [53] . The spectral m aker for TTR  fibril form ation is the band at 
1625 cm -1 .
Table 2. IR marker bands of abnormal protein aggregation.
Marker Band of the 
Aggregation [cm-1] Assignment Peptide Reference
amide I (1700-1600 cm 1)
amyloid p1_42 [40,41]





1693-1685/1623-1613 antiparallel p-sheet amyloid p 11-28 fragment and its mutants in 21-23 position [31]
1692/1620 antiparallel p-sheet HET218-289 [55]
1691/1630 antiparallel p-sheet A p 42CC oligomers/protofibrils [32]
1688/1620 antiparallel p-sheet human lysozyme, oligomers [29]
1686/1616 antiparallel p-sheet transthyretin (TTR) soluble aggregates [52]
1686/1614 antiparallel p-sheet hen egg white lysozyme (HEWL) [56]
1684/1616 p2-microglobulin (short curved structures) [54]
1684/1612 antiparallel p-sheet SH3 domain, amorphous aggregates, non-fibrilar [57]
1683/1612 t ^ antiparallel p-sheet insulin oligomer [39]
1678-1670 p-turns amyloid p 11-28 fragment and its mutants in 21-23 position [31]
1670 p-turns amyl°id p1-42 oligomers and fibrils a-synuclein
[40]
[28]
1669 p-turns HET218-289 [55]
1667-1661 310-helix E22K and A21G mutants of Ap(11-28) fragment [31]
1664 p-turns SH3 fibrils/pepsin digested [57]
1660-1650 random coil and/or amyloid p1-42 oligomers and fibrils [40]helical structures a-synuclein [28]
1659-1652 a-helix amyloid p 11-28 fragment and its mutants in 21-23 position [31]
1658 Turns monomers, oligomers, human lysozyme fibrils [29]
1655 random coil HET218-289 [55]
1649 unstructured SH3 amorphous aggregates [57]
1648-1639 random coil amyloid p 11-28 fragment and its mutants in 21-23 position [31]
1648 random coil PrP82-146 [51]
1644-1641 disordered/loops
disordered
human lysozyme oligomers, fibrils [29]
1641 structures SH3 fibrils/pepsin digested [57]
1635-1624 p-sheet amyloid p 11-28 fragment and its mutants in 21-23 position [31]
1633 parallel p-sheet Sup35 crystals, prion-like [58]
1630 parallel p-sheets HET218-289 [55]
1630-1623 parallel p-sheet amyloid p1-42 fibrils amyloid p1-40
[40,41]
[42- 44]
1630-1614 parallel p-sheet human lysozyme fibrils [29]
1628 parallel p-sheet a-synuclein fibrils [28]
1626 t parallel p-sheet PrP82-146 fibrils [51]
1626 t ^ parallel p-sheet insulin fibrils [39]
1625 parallel p-sheet transthyretin (TTR) fibrils [52]
1620-1618 p 2-microglobulin, fibrils [54]
1620-1600 p-sheets hen egg white lysozyme (HEWL) [56]
1618 ^ parallel p-sheet SH3 fibrils/pepsin digested [57]
t  increase in intensity, ^  shift towards higher wavenumbers after aggregation, ^  shift towards lower wavenumbers 
after aggregation.
In addition to neurodegenerative peptide aggregation, the secondary structure of amyloid fibrils 
of other non-neurodegenerative peptides has also been extensively studied. The IR  m arker bands of
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abnorm al protein aggregation have been  determ ined for p2-m icroglobulin ( p2m ), w hose deposits 
occurred in d ialysis-related am yloidosis w ith in  the m usculoskeletal system  [54], a prion-form ing 
2 18 -2 8 9  dom ain of H ET protein [55], w ild-type hum an lysozym e [29] and hen egg w hite lysozym e 
(HEW L) [56] (see Table 2). These proteins have been studied as great m odels of am yloid aggregation. 
Zurdo and co-w orkers [57] characterized the fibrils form ed by the SH 3 dom ain of the a -su bu n it of 
bovine phosphatidylinosito l-3 '-kinase. The FTIR  spectra w ere collected for am orphous aggregates 
as w ell as for fibrils (created at low  pH ) exposed to pepsin to receive a sam ple containing only a 
fibrillar structure w ith  characteristic low  frequency band for parallel p-sheets (1618 cm -1 ). A nother 
am yloid-like structure form ed from  a prion-like protein, Sup35, derived from  yeast, w as studied by 
Balbirnie et al. [58]. FTIR spectra of aggregated protein crystals showed the 1633 cm -1 parallel p-sheet 
band. The aggregation kinetics of hum an islet am yloid polypeptide (hIA PP) w as studied using 2D  
infrared spectroscopy com bined w ith  site-specific isotope labeling [59]. This m ethodology allow ed 
to follow  the intensity  grow th of the 1617 cm -1 peak related to the increase of p-sheet content upon 
aggregation and fibril formation. Ami et al. [60] incorporated the FTIR microscopy to study aggregates 
of am yloidogenic im m unoglobulin  light chains (LCs) occurring in the light chain  (AL) am yloidosis 
pathology. The applied m ethodology involved the FTIR  in situ studies o f unfixed tissues (hear and 
subcutaneous abdom inal fat) derived from AL am yloidosis affected patients as w ell as the research of 
in vitro aggregated peptide (derived from a patient). The infrared p-sheet signature characteristic for 
am yloid aggregation w as possible to detect in situ in the spectra of tissues.
2.1. Infrared Spectroscopy at the Nano Scale in Studies o f Abnormal Proteins/Peptide Aggregation
D ue to the diffraction lim it, the resolution of conventional IR  spectroscopy does not m ake it 
possible to track changes concerning single m olecules. The signal reaching the detector contains 
bulk inform ation, averaged over m any m olecules of the studied sam ple. To overcom e this lim itation 
and follow  the IR  absorbance spectra at the single m olecule level, the novel nano-FTIR  and A FM -IR 
techniques have been im plem ented.
2.1.1. N ano-FTIR In Studies of A bnorm al Proteins/Peptide A ggregation
The nano-FTIR  technique m akes it possible to achieve sim ultaneous infrared chem ical and 
topographic characteristics of a sample at nanoscale resolution. It became possible due to the invention 
of scattering-type scanning near-field optical m icroscopy (s-SNOM), which is a unique com bination of 
atomic force m icroscopy (AFM) w ith optical im aging and IR spectroscopy [61]. N ano-FTIR com bines 
the nanom etric spatial resolution of AFM  w ith  the chem ical sensitivity of IR  spectroscopy. The local 
probing of m olecular v ibrations involves the incident light scattering a t an A FM  tip apex (Figure 2 ). 
The electric charge accum ulated on the probe apex generates a localized electric field. W hen the AFM  
probe (usually m etallic) is in contact w ith the sam ple, it is possible to detect the near-field interaction of 
infrared light w ith the sam ple due to the induction of a local evanescent field [61]. D epending on the 
m easurem ent purposes, the nano-FTIR technical setup provides a broadband mid-infrared laser (fiber 
laser plus difference frequency generator) or tunable single line laser (quantum  cascade laser, QCL). 
Both of these light sources enable chem ical im aging, the broadband laser m akes it possible to obtain 
the hyperspectral maps and the QCL provides maps at the fixed wavelength. W hen the interferom eter 
is operating as a Fourier transform  spectrometer, it is possible to collect single FTIR spectra at points of 
interest on the sam ple, selected precisely based on the AFM  im age [61].
N ano-FTIR  w as em ployed to study am yloid aggregates by A m enabar et al. [61]. In this w ork, 
it was shown for the first time that nano-FTIR can be used to study the secondary structure of individual 
proteins. Amenabar and co-workers explored the conform ation of single insulin fibrils. The nano-FTIR 
spectra of insulin fibrils (Figure 3) revealed the bands characteristic for p-sheets at 1639 cm -1 , a-helical 
structures at 1671 cm -1 and the band at 1697 cm -1 w hose authors attributed to p-turns or antiparallel 
p-sheet. The w eak band at 1609 cm -1 w as assigned to am ino acid side chains. The im ages at single
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w avelengths provided by  Q C L laser (Figure 3c) as w ell as single broadband spectra (F ig u re 3d ) 
confirm ed the? presence of a-helices in 3-nm  and 9 -n m th ick  fibrils.
Figure 2. The schematic representation of infrared nanospectroscopy principles: thermal extension of a 
sample and a change of AFM centilever deflection, as a consequence of the interaction with the Sncident 
IR light (AFM-IR) and scatteringof the near infrared field from tire sample at the metal/metalized probe 
apex fnano-FTIR).
Figure 3. Infrared nanospectroscopyand nanoimaging of insulin fibrils. (a) AFM topography image of 
insulin fibrils, scale bar: 200 nm; (I) 3-nm thick type I fibril, (X) a 9-nm-thick fibril, (b) the nano-FTIR 
spectrum (red curve) based on five absorption bands. (c) s-SNOM phase images of the fibrils at fixed 
wavelengths, scale bar: 0500 nm. (d) Single infrared absorption spectra at the positions marked in (a), 
eopography image [61]. Images reproduced under CC BY license.
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2.1.2. Infrared Spectroscopy Com bined w ith Atom ic Force M icroscopy (AFM -IR) in Studies of 
A bnorm al Proteins/Peptide Aggregation
Infrared nanospectroscopy, also called Phototherm ally  Induced R esonance (PTIR) or infrared 
spectroscopy coupled w ith  atom ic force m icroscopy (A FM -IR), enables the m easurem ent of a local 
infrared light absorption  [62].  Thanks to the use of tunable infrared lasers it is possible to obtain 
single spectra or m aps show ing the spatial distribution of selected m olecules and their functional 
groups. C onventional spectroscopic m ethods, such as IR  or R am an spectroscopy, are lim ited by the 
diffraction criterion. The spatial resolution of these techniques depends on  the w avelength and is 
in the range of 5 -1 0  pm [63]. Therefore, they cannot be applied in im aging of m icro- or nanom etric 
biological objects. The PTIR  m ethod has been  first dem onstrated in 2005, by  prof. A. D azzi from  
Universite Paris Sud [62- 64]. This technique is based on the detection of infrared radiation absorption 
using atom ic force m icroscopy (AFM ). Transient and local sam ple extension are detected as a change 
of A FM  cantilever deflection (Figure 2 ) . Phototherm ally  induced signal increases w hen the laser is 
tuned to frequencies which are absorbed by the sample. The lim itation of AFM -IR spatial resolution is 
determ ined by scanning and sam pling rates and is related to several factors such as the tip apex size 
and therm om echanical properties of the investigated sam ple [62- 64].
An application of AFM -IR in the structural organization of individual fibril aggregates is of central 
im portance for several scientific groups. Henry and co-workers studied the amyloid (3 (A p 1 - 4 2 ) peptide 
and its G37C m utant at the nanoscale [65]. They used AFM -IR to examine the interaction of lipids such 
as 1-palm itoyl-2-oleoylphosphatidylcholine, sphingom yelin, or cholesterol w ith  am yloid aggregates. 
It w as discovered that aggregation of am yloid 3 1 -4 2  and its m utant essentially changes the structural 
organization of the fibrils in the presence of the investigated phospholipids. R uggeri e t al. applied 
AFM -IR to investigate single aggregates of a highly fibrillogenic domain of ataxin-3 called “Josephine" 
and followed its w hole aggregation pathway [66]. They observed that already at the first aggregation, 
abnormal folding of Josephine w as formed. It was possible to detect conform ational transitions starting 
from  native oligom ers to m isfolded oligom ers and finally to m ature am yloid  fibrils. Ruggeri and 
co-w orkers also studied E x o n l aggregation w hich is the first exon of H ungtinton protein [67]. They 
determ ined the influence of the polyQ  content and the N t17 dom ain occurrence on the biophysical 
features of Exon1 fibrils. In the presence of the Nt17 domain, the IR spectra of fibrils revealed the peak 
characteristic for p-turn rich secondary structure at 1684 cm - 1 w hile the lack of this dom ain changed 
the secondary structure of fibrils w hich  displayed antiparallel p-sheet structure. R izevsky et al. [68] 
studied insulin  fibrils using A FM -IR. In  the follow ing w ork, the form ation of tw o different types of 
fibers w as described. This phenom enon is associated w ith the insulin aggregation pathway. The first 
fibril type had an p-sheet-rich secondary structure, w hereas the second polym orph revealed m ainly an 
unordered secondary structure. G alante and co-w orkers [69] studied the influence of the m ost toxic, 
pyroglutamylated isoform of amyloid p (Ap pE3-42) on the biophysical features and biological activity 
of am yloid P1 -4 2  [70,71]. It w as confirm ed that the m ixture of ApE3-42/A1-42 w ith the 5%  content of 
AppE3-42 isoform was the m ost toxic. Ramer et al. [72] applied AFM -IR for the first time to investigate 
the chemical structure of amyloid aggregates at the nanoscale in water. They demonstrated that it was 
possible to collect PTIR  spectra in liquid w ith  a high signal-to-noise ratio. They studied aggregates 
of diphenylalanine (FF, Figure 4b ), w hich is the core am yloid p peptide, and its tert-butoxycarbonyl 
derivative (Boc-FF, Figure 4a). It was confirm ed that the detection of differences in the studied fibrils is 
possible for measurements conducted in liquids. Boc-FF appeared to have a more helical conform ation 
in com parison to FF. These results are prom ising, and m ake it possible to state that A FM -IR  can be 
w idely  used for very com posed aggregation system s in liquids. A FM -IR  m arker bands related w ith 
the neurodegenerative peptide aggregation are presented in Table 3 .
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Figure 4. PTIR structural comparison of FF and Boc-FF fibrils in D3O. Chemical structure and AFM 
morphology maps of (a) Boc-FF and (b) FF fibrils. (c) Comparison of the fibrils averaged PTIR spectra 
in the amide I (green and yellow) and C=O stretching vibration (red) spectra ranges. (d) Comparison 
of the second derivatives spectra in the amide band I region [72].
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Table 3. AFM-IR marker bands of the neurodegenerative peptide aggregation.
Marker Band of the 
Aggregation [cm-1] Assignment Peptide Reference
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unexpanded Exon1 (22Q), 
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amyloid p 

















amide II (1600-1500 cm-1)
1580-1510
1555,1520







1605,1495,1452,1430 C-C ring vibrations FF [72,73]
amide III (1400-1200 cm-1)
1350-1200 v(C-N), 6(N-H),v(C-C), 6(C=O) ataxin-3 [38,66,70,71,75]
v—stretching, 6—bending, bk—backbone.
3. Ram an Spectroscopy in Studies of Abnorm al Proteins/Peptide Aggregation
R am an spectroscopy is a non-destructive analytical technique that m akes it possible to obtain 
inform ation about the chem ical structure and com position of the investigated sam ple. The basic 
phenom enon used in this method is an inelastic light scattering, w hich contains inform ation about the 
energies of the vibrational states [77] (the light scattering m echanism  is shown in Figure 5 ). The energy 
difference betw een incident radiation and scattered radiation is corresponding to the energy levels of 
vibrational modes in functional groups of the investigated molecules. This process causes the excitation 
of characteristic vibrations, w hich are observed in the spectrum  as specific bands [77,78].







Stokes _ , . ,  anti-Stokes
Raman Raman,, . scattering .. .scattering °  scattering
Figure 5. During non-resonant light scattering, three scenarios are possible: in the middle, elastic 
scattering;, called Rayleigh scattering (without energy changes), on sides inelastic light scattering 
(causing energy changes), called Raman scattering including anti-Stokes (higher energy of scattered 
photon), and Stokes (lower energy) lines.
In respect to these relationships there is a selection rule, and according to this, the polarity of the 
m olecule m ust change. Inelastic scattering, also called Ram an scattering, is very rare. A pproxim ately 
only one photon per 1010 is scattered inelastically [78]. For this reason, various methods to amplify the 
signal are proposed, such as surface and tip-enchanted R am an spectroscopy, w hich are described in 
the next paragraphs of this article. Ram an spectroscopy is w idely used in the study of various types of 
biological m aterial [79], and its use in m edical diagnostics is being considered [80,81].
D eep UV Resonance Ram an (DUVRR) Spectroscopy is a variant of the Ram an spectroscopy very 
com m only used in the research of protein aggregation. In contrast to Non-resonance or Norm al Raman 
(N R) Spectroscopy, the radiation used in the experim ent (in this case U V  spectral range) transfers the 
electron to a higher energy state, w hich  causes resonant am plification of the scattered light signal 
(Figure 6). Thus, it becom es possible to observe bands that are less visible in the N R m ethod [82,83].
As a result of the aggregation process, structural transformations occur in proteins, w hich m anifest 
as characteristic changes in the Ram an spectra (Table 4). An increase in the intensity of the bands from 
am ide I and II is observed, due to the form ation of p-sheets. This process w as observed in various 
forms, depending on the proteins tested [84- 86]. Kurouski et al. observed an increase in the intensity of 
amide I and II bands in the formation of insulin fibrils [86], while in the case of hen egg white lysozyme 
(H EW L) studied by  R osario-A lom ar et al. only  the change of am ide II w as v isib le [85]. In  addition, 
a shift of amide I and II bands towards higher energies was observed [85,86]. The second characteristic 
marker that almost always appears is an increase in the intensity of the C a -H band at 1390 cm -1 , w hich 
is explained by the decay of a-helix  into a disordered structure [85,87]. In addition, there are changes 
in the intensity of the com plex amide III band. Xu et al. described an increase in intensity in the range 
of 1270-1320 cm -1 and a decrease in the range of 1230-1270 cm -1 [88].
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Figure 6. Comparison of NR and DUVRR spectroscopy. In NR, the electron is not transferred to a 
higher energy state, but only to a virtual state (lower energy than Sj). In DUVRR, the radiation scattered 
on the sample excites the electron to the S1 state energy, causing the resonant signal amplification.
Table 4. Raman marker bands of peptide aggregation.
Marker Band of the 
Aggregation 1 Assionment Peptide Referenci
amide I (1700-1600 cm 0
1690-1600 11672— P-sheets formation insulin, hen egg white lysozyme (HEWL) [85,86,88]
amid e II (1580-1480 cm-1)




of peak intensity, 1 o decree








523, 507 1490 
540, 510 1508
1000 1
1 7 an increase i
1-SS-casboxymethyl lactalbulOn (1-SS-LA), 
HEWL









ise of peak intensity, —> a peak shift to hijjher energy
In the spectra of aggregated proieins, there iio fte n  a change in the b an d's intens ity from individua l 
am ino acids. In particular, a characteristic peak for phenyloalanine (100-4 cm -1 ) is often described as 
one of the specteoscopic markers of fibrillation [88]. In some cases, there is a significgnt decrease of Phe 
band intensity  [87,88], w hich  is explained by  nhe change in tine chem ical environm ent of this am ino 
acicL However, this ch ange is not always observed [86].
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Interesting changes in Ram an spectra were detected for the disulfide band in the range of 450-550 
cm -1 . Kurouski and Lednev observed significant changes in the spectrum for apo-a-lactalbum in (LA) 
and 1-SS-carboxym ethyl lactalbum in (1-SS-LA ) [84]. In the spectra of native LA , tw o peaks w ere 
observed at 510 cm -1 and 530 cm -1 due to various secondary structures. In  LA  fibrils, the p-sheets 
structure is m ainly  predom inant; therefore, in their spectra, one peak a t 508 cm -1 w as observed. 
In turn, 1-SS-LA showed a slightly more complex structure, but also in this case a significant change in 
the spectra related to secondary structure transition w as visible. Sim ilar studies w ere carried out by 
Rosario-Alomar et al. for HEW L. Along w ith ongoing fibrillation, two peaks at 507 cm -1 and 523 cm -1 
merged into one at 490 cm -1 [85].
3.1. SERS In Studies o f Abnormal Proteins/Peptide Aggregation
Surface-Enhanced R am an Spectroscopy (SERS) is based on the enhancem ent phenom enon in 
R am an scattering by the application of nanostructures consisting of noble m etals, transition m etals, 
or sem iconductors. For all m olecules adsorbed onto nanostructured m etal surfaces inelastic light 
scattering is greatly enhanced (enhancement factor can be up to 1010) in com parison to free molecules [89]. 
It is considered that the SER S effect is a com bination of tw o m echanism s: an electrom agnetic field 
enhancem ent (EM) and chemical surface interactions. EM field enhancem ent is caused by the excitation 
of surface plasm ons on the surface due to the interaction betw een the electrons in metal nanostructure 
w ith  the incident electrom agnetic radiation. The locally enhanced electrom agnetic field on the 
nanoparticle surface strongly increases the intensity of Raman scattering, because the Ram an scattering 
cross-section is proportional to the electrom agnetic field. O n the other hand, the R am an scattering 
cross-section also strongly depends on the polarizability of the investigated m olecule. C hem ical 
enhancem ent is attributed to a significant increase in  the polarization of the m olecules due to its 
absorption onto the m etallic surface, w hich  results in  the charge transfer affecting significantly the 
polarizability. N ew  energy states are created that can be excited w ith  the laser beam . This R am an 
resonance enables electron transfer from the Fermi level of the metal to the lowest unoccupied molecular 
orbital of the molecule (LUMO) and from the highest occupied molecular orbital (HOMO) to the Fermi 
level of the m etal. The chem ical enhancem ent is less effective and strongly depends on the type of 
adsorbed m olecules, w hile the electrom agnetic enhancem ent is universal for all m olecules [90,91].
D uring the last decade, SER S has becom e quite popular as one of the m ost sensitive analytical 
techniques in  chem istry, m aterial science and biotechnology. It provides inform ation about 
conform ational and structural changes in  m olecules a t very low  concentrations. H ow ever, protein 
investigation still rem ains challenging. First of all, SER S m easurem ents suffer from  low  spectral 
reproducibility. The SER S enhancem ent factor is strongly determ ined by the distribution of 
nanoparticles. Variations in spectral characteristics are therefore induced by inconsistent aggregation 
and collocation of the nanoparticles. Thus, the uncontrolled enhancem ent of signal from  proteins 
adsorbed on the SER S-active surface generates SER S spectra w ith  low  reproducibility. M oreover, 
proteins, as the intrinsic m olecules, often form  com p lex SER S patterns, w hich  m akes identifying 
characteristic R am an fingerprints d ifficult [92- 94]. To overcom e this lim itation, it is im portant to 
ensure that protein binding to a SER S-active substrate is consistent and w ell understood. C onstant 
enhancem ent and reproducibility of SERS substrate preparation are therefore of central im portance.
Due to the fact that SERS technology provides inform ation about the secondary structure, it allows 
for an understanding of properties and functionality of the abnorm al protein aggregates at very  low  
concentrations. SERS m arker bands associated w ith the abnormal amyloid aggregation are summarized 
in Table 5 . O ne of the first SER S studies on protein aggregation concerned am yloid  p [95]. C hoi 
et al. used a nanofluidic device w ith  SER S active gold nanoparticles to determ ine and characterize 
various stages of am yloid p aggregation. To understand conform ational changes induced by protein 
aggregation, SERS spectra were collected as a function of time and protein concentration. The analysis 
of the am ide III band allow ed to investigate the form ation of am yloid  aggregates, the decrease in 
a-helics and the increase in p-sheet at m icrom ole to fem tom ole concentrations [96]. A  sim ilar study
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w as conducted by  a group from Texas U niversity [97]. Further research related to the conform ational 
changes of am yloid aggregates w as provided. Bhow m ik et al. used Surface-Enhanced R am an 
Spectroscopy w ith  silver nanoparticles to determ ine the Ap oligom ers structure that spontaneously 
bind to lipid bilayer. The secondary structure inform ation of individual residues w as exam ined 
based on R am an isotope shifts. The authors determ ined that the structure of A p 4 0  oligom ers bound 
to the m em brane, d isp lay p-turn in  the 23-28 region, situated betw een antiparallel p-sheets [98]. 
Insulin  aggregation has also been investigated. K urouski et al. used surface-enhanced R am an 
scattering to study the kinetics of insulin aggregation followed via detection of the insulin prefibrillar 
oligom ers secondary structure. Insulin  at different stages of aggregation w as m ixed w ith  90 nm  
of A u nanoparticles. SER S analysis dem onstrated a m ore than tw o-fold  increase in  the num ber of 
insulin  oligom ers after the first hour of incubation. Further protein incubation  resulted in a slow  
decrease in oligomers amount. The observed decrease in the quantity of prefibrillar species w as linked 
to their conversion into fibrils [99]. Li et al. d iscovered that brom ophenol b lue (BPB) potentially  
inhibits the insulin fibrillation process [100]. Karabelli et al. used the electrochem ical SERS (EC-SERS) 
m ethod to study interaction betw een interm ediates occurring at various stages of insulin aggregation 
and b iom im etic m em brane. It w as observed that protofibrils and oligom ers evoked significant 
m em brane perturbation, w hereas the native protein seem s to have a protective role. The authors 
presented one of the first applications o f the EC -SER S technique to investigate protein aggregation 
interm ediates-biom em brane interactions [101] . Yu et al. discovered a m ethod that m akes it possible 
to d istinguish A p 4 0  and Ap 4 2  peptides easily. SER S com bined w ith  principal com ponent analysis 
(PCA) revealed changes in  peptide conform ation and self-association [102]. U ndeniably, SER S has 
great potential in peptide/protein studies, continuous w ork on increasing spectrum  repeatability will 
certainly provide a deeper understanding of protein aggregation.
Table 5. SERS marker bands of the neurodegenerative peptide aggregation.
Marker Band of the Aggregation Assignment Peptide Reference











amyloid p 1_42 [95,96]
CCN stretching
1144 4 amyloid p 1_42 [96]
C-C stretching
960 4 amyloid p 1—42 [95]
4 a decrease of peak intensity, 4an increase of peak intensity
3.2. TERS In Studies o f Abnormal Proteins/Peptide Aggregation
Tip-enhanced Raman Spectroscopy (TERS) takes the advantage of the nanometric spatial resolution 
from  Scanning Probe M icroscopy (SPM ) including A tom ic Force M icroscopy (AFM ) or Scanning 
Tunnelling M icroscopy  (STM ), and the chem ical selectivity  of R am an spectroscopy. Therefore, 
it provides inform ation about the m olecular structure and com position w ith  nanom etric spatial 
resolution [103]. The excitation of surface plasmons in a metal nanostructure, w hich can be deposited on 
the apex of an AFM tip (AFM-TERS) or in STM tip apex itself (STM-TERS), modifies the electromagnetic 
field of incident laser light [103,104]. The R am an scattering cross-section is proportional to this 
electrom agnetic field, and due to the enhancem ent, it can be dram atically  im proved. W hat is m ore, 
the generated electrom agnetic field is highly localized; therefore, spectra are acquired from the sm all
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amount of sample located directly under the tip [103,104]. TERS tip can be understood as a nanoantenna. 
It converts the electric field of the R am an laser into highly  spatially confined energy [105], breaking 
the R ayleigh 's diffraction lim it, and im proving the spatial resolution to a few  nanom eters. O n the 
other hand, TERS probe converts the near field of the sam ple to a far field, accessible to a m icroscopic 
objective, increasing the sensitivity to the single m olecule level [106- 108]. In  recent years, TERS has 
m ainly been applied for sam ples w ith a high natural Ram an scattering cross-section including carbon 
nanotubes and dyes [106- 108]. The m ain lim itation of TERS is actually related to its h igh sensitivity. 
The R am an scattering cross-section of carbonaceous substances and contam inations is exceptionally 
high [109]. Even thin traces of carbon contam inations can be easily  detected as rapidly fluctuating 
and sharp peaks, w hich averaged over m any spectra result in the broad D- (1360 cm -1 ) and G-bands 
(1580 cm -1 ) [109]. A  very  strong electrom agnetic field, how ever, could dam age delicate b iological 
sam ples and cause their photochemical/thermal decom position.
TER S delivers highly resolved topographic inform ation and provides a chem ical com position of 
the investigated sam ple. Therefore, this analytical technique is potentially ideal for studying protein 
secondary structure and its m odification upon the fibrillation process. How ever, TER m arker bands 
required for secondary structure identification such as amides I and III or C-H/N-H motions, allowing for 
conform ation detection based on spectral positions, are mostly not well resolved. In particular, the most 
inform ative am ide I band is absent in TER  data. This problem  has been broadly discussed [110- 112], 
and finally it w as proved that peptide backbone bonds m ay dissociate in  the laser hot spot, w hich 
causes the lack of the amide I band. An application of the mid m easurem ent condition (reduced laser 
exposition tim e and laser power) prevents the decom position of the peptide backbone im proving the 
spectra quality.
D ue to the TER S lim itations m entioned in the previous paragraphs, m easurem ents of biological 
samples including proteins are still very limited. However, the results obtained so far are undoubtedly 
very  valuable and should be presented in  this review. For clarity, TER m arker bands related to the 
abnorm al am yloid aggregation are presented in Table 6 . O ne of the first neurodegenerative peptides 
characterized w ith TERS w as p2-m icroglobulin [113]. Several polypeptides w ere intensively studied 
by the group of prof. D eckert from Jena University. D eckert and co-w orkers applied TERS to analyze 
the surface m olecular structure of hum an islet am yloid  polypeptide fibrils, proving that the highly 
heterogeneous fibril surface m ainly contains a-helical or unordered structures, in contrast to the fibril 
core, w hich  is bu ilt of p-sheets [114]. Insulin  fibrils w ere also investigated. K urouski et al. probed 
the chem ical com position and the secondary structure of insulin fibrils [115], dem onstrating the high 
capability  of TER S in characterization of heterogeneous fibrils. Insulin  w as also applied to test the 
efficiency of several aggregation inhibitors including: benzonitrile , d im ethylsulfoxide, quercetin, 
and p-carotene [116]. Analysis of the shape of the amide I band in the TERS spectra m akes it possible 
to detect the influence of these inhibitors on fibrils secondary structure [116]. It w as proven that all 
insulin aggregates showed sim ilar m orphology but various inhibition results in their different p-sheet 
structure content, suggesting serious m odification in the aggregation pathway. Specifically, the authors 
suggested that prevention of the p-sheet stacking of the peptide chains played a m ajor role in the 
aggregation inhibition [116]. A dditionally, the group from  Jena identified the secondary structure 
of insulin  aggregates via the am ide III band and w hat is m ore, perform ed successful detection of 
hydrophobic and hydrophilic domains on the surface [117]. Bonhom m eau et al. characterized A p 1- 4 2  
and its two synthetic, less toxic mutants at the nanoscale. Based on the exam ination of amides I and III 
bands, detection of fibers organized in parallel p-sheets and in anti-parallel p-sheets w as possible.
M olecules 2020 , 25, 2498 17 of 26
Table 6. TER marker bands of the neurodegenerative peptide aggregation.
Marker Band of the 
Aggregation [cm-1]
Assignment Peptide Reference









amyloid p 1.4 2 , insulin, 
p2 -microglobulin 
hIAPP (Amylin) 
amyloid p 1-42 
hIAPP (amylin), insulin
[111,113,115- 118]
[1 1 2 ]
[117]
[112,113,115,118]
C a  H/N-H (1370-1360 cm-1)
1364 T p -sheets amyloid p1-42 [116]





parallel p -sheets 











4 a decrease of peak intensity with the ongoing fibrillation, T an increase of peak intensity with the ongoing fibrillation.
In previous studies, single-point TER spectra were mainly acquired at selected locations. However, 
recently, hyperspectral TER  m apping, w hich  consists of a full T ER S spectrum  in  each pixel of 
the im age, w as perform ed. Paulite et al. successfully applied STM -TER S to m ap A p 1-40 through 
integration of the phenylalanine ring breathing mode [119]. The highly reproducible and intense peak 
from  phenylalanine at 1004 cm -1 dom inates each STM -TER  spectrum ; how ever, am ides w ere not 
w ell resolved. Recently, A FM -TER S w as applied for nano-spectroscopic hyperspectral m apping of 
am yloid p1- 4 2 . A n application of A FM -TER S allow ed for localization of p-sheet and unstructured 
coil conform ation distribution in oligom ers and along fibrils and protofibrils [118]. These studies 
confirmed the high capability of TERS in the mapping of amyloids, and w hat is more, they allowed for 
direct m onitoring of aggregation pathways by following the distribution of the secondary structure in 
individual aggregates: oligomers, protofilaments, and fibrils. Figure 7 demonstrates the AFM im age of 
A  p1-42 deposited on a gold surface. The zoom ed-in  area is partially  overlapped by  the TER S m ap 
in the central part. Two types of TER  spectra, presented below  the m aps, w ere acquired in the area 
of the individual fibril. The distribution of each of those spectra is superim posed on the zoom ed 
A FM  topography. The m ain difference betw een the tw o types of spectra acquired from  the fibril is a 
significant shift of the am ide III band from 1260 cm -1 (green spectrum ) to 1250 cm -1 (blue spectrum ). 
The position of the amide III band indicates the particular peptide secondary structure: turns/random 
coil and p-sheet conform ation, respectively. The distribution of these conform ations along a single 
fibril is presented in  the zoom ed-in  area. A nother characteristic m arker of p -sh eet structure, w hich 
can be observed in the blue spectrum, is a high intensity of the C a - H/N-H bending mode at 1364 cm -1 
(Figure 7). Despite the absence/low intensity of the amide I band in the studies described above, it was 
confirm ed that TERS is an efficient tool for investigation of the am yloids secondary structure and for 
direct verification of the aggregation pathw ay [118].
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Figure 7. AFM-TER mapping of Af31—42 fixed on gold: .AFM topography with overlapped TERS map 
in zoomed area showing the distribution o f |3-sheets (blue) and turns/unstructured coils (green) with 
corresponding averaged TERS spectra, characteristic for laoth conformations; adapted with permission 
from [118].
4 . M ultivariate D ata Analysis in Studies of Abnorm al Proteins/Peptide Aggregation
The m ain purpose of perform ing a m ultidim ensional statistical analysis (M SA) on spectroscopic 
data is to pcove that mea/ueed spectral diffeeences exist accoeding to different populations and this 
inform ation i s statiitically  significant . The /ubject of consideration s in m ultid im ensional statistical 
analysis is a large set of data dessribing the studied phenom enon by m eans of vectors. M SA m ethods 
make it possible to organize this data, establish relationships betw een variables, as well as to estimate 
param efers and verify hypotheses of interest. Classical m ultivariate statistical analysis w as developed 
assum ing that the; observable random  vectors have norm al distributions. However, in recent decades, 
fheee leas been a rapid developmenS of nonparam etric m ultidim ensional statisticai analyris. Principal 
Com ponent Analysis (PCA) and Hidrarchical Cluster Analysis (HCA) are the m ost popu lar. Hewever, 
in contrasi to the PCA  m ethod, the use of H C A  is not lim ited to all-num eric data. In the case ot the 
spectroscopic meShodo w ith  the single-m olecule sensitivity  as SER S, TER S, A FM -IR  or nano-FTIR , 
the details obtained by performing the M SA analysis c annot be im mediately apparant from the separate 
analysis of peak intensities. The difeerent approach is com m only used in Ramon or IR techniques due 
to the greater signal-to-noise eatio in those m ethods.
M any techniques have been developed to sim plify data analysis, especially in the c ase of difficulties 
w i t i  interpretation of large data sets. Principal com p onent analysis (PCA ) is one of the oldest and 
m ost w idely  used techniques in this area. The m ain idea of PC A  is to drastically  reduce dataset 
d im ensionality in an interpretable w ay w ithout a significant loss of statistica l in form ation  The basic 
requirem ent in PCA  is to successively  m axim ize variance and finally  to find new  variables that are 
linear functions of those in the original dataset. Therefore, it finally leads to an eigenvalue/eigenvector 
problem solution. PCA was firstly incorporated for data analysis by Pearson [120] and Hotelling [121].
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Although PCA needs no distributional assum ptions, a m ultivariate norm al distribution of the dataset 
establishm ent is com m only used. This m ethod is an exploratory adaptive and can be used on various 
num erical data types. The PCA  m ethod m akes it possible to reduce the noise and to detect the 
sub-groupings w ithin  the spectra. The m ost im portant results o f PCA  are the score plots and the 
loading plots. The score plots represent the degree of variability  w ith in  the totality  of spectra and 
the loading plots show  w hich  variables in the data set are responsible for the greatest degree of 
separation [122,123].
The overall goal o f hierarchical cluster analysis (H C A ) is sim ilar to that of PCA , bu t the 
m athem atical approach is different. The H C A  is typically  applied to determ ine how  entities can be 
grouped into clusters, that exhibit h igh sim ilarity  w ithin-group and low  sim ilarity to other groups. 
The result of H C A  is usually presented as a dendrogram , w hich is a plot that show s the relationships 
betw een the sam ples in a tree form . In  H C A , tw o m ain approaches (agglom erative and divisive) 
are used to resolve the grouping problem . In the agglom erative approach, each sam ple is initially 
considered as a cluster, and subsequently, pairs of clusters are m erged. The divisive approach is 
contrary, the algorithm  starts w ith  one cluster including all of the sam ples, and recursive splits 
are perform ed. C lustering is achieved by the use of an appropriate m etric of sam ple distance and 
linkage criterion am ong groups. The m ost com m only used, in the case of the datasets obtained from  
m entioned techniques, are Euclidean or M anhattan  distance in  com bination w ith  W ard's m ethod 
linkage. C lustering can be used for the identification of interesting patterns and distributions in the 
data structure. Therefore, it is a useful technique for discovering and extracting inform ation that may 
previously have been unnoticed [124] . C luster analysis w as proposed in 1930; how ever, it has found 
applications across a w ide variety  of disciplines since the beginning of the early 1960s. O ne of the 
prim ary difficulties w ith  the application of H C A  for the extraction of significant inform ation is the 
choice of the optim al num ber of clusters. This problem  is still considered to be im portant despite 
several activities concerning this field. A lthough several criteria are available to assist in the proper 
selection of the appropriate num ber of clusters, the results depend on the researcher.
PCA w as used to analyze spectroscopic data concerning amyloid aggregation for the first time by 
R uggeri et al. [66] . The authors perform ed the PC A  by  m eans o f the nonlinear iterative partial least 
squares algorithm  w ith  cross-validation and m ean-centered data analysis of underivatized spectra 
and second derivatives calculated after an application of the Savitzky-G olay algorithm  for smoothing. 
This analysis confirm ed that shifts of the am ide I (from  1655-1620 cm -1 to 1710-1680  cm -1 ) and the 
am ide III bands (from  1380 to 1295 cm -1 ) are spectral m arkers of the Josephine dom ain of ataxin-3 
protein aggregation. The secondary structure of the studied dom ain changed from  the random  
coil/a-helical structure in native protein to p-turn/antiparallel p-sheet conform ations in aggregated 
forms [66].
The HCA analysis w as perform ed to obtain the averaged TERS spectra used as the reference for 
assigning the tw o conform ations, turns/random coils, and p-sheet in the analysis o f TER  m aps [99]. 
The correlations betw een each single spectrum  from  the acquired m aps and the m arker spectra 
determined by HCA were estimated w ith Pearson's correlation coefficient. Calculations were performed 
using not the raw spectra, but rather their second derivatives to avoid any influence from the baseline. 
The sam e m aps were also analyzed using principal com ponent analysis for the statistical com parison. 
The m ultidim ensional statistical analysis allowed to dem onstrate the distribution of the turns/random 
coils and p-sheets secondary structures in individual am yloid p 1 -4 2  aggregates, therefore, Lipiec et al. 
verified spectroscopically several hypothetically proposed aggregation pathw ays [118].
The PCA performed on the SERS data allowed to distinguish amyloid p isoform s, A p1- 4 0  associated 
w ith classical vascular and A p 1- 4 2 , related to parenchymal vascular plaques in the A lzheim er's Disease. 
Five different w avelengths w ere analyzed using the PC A  m ethod to m axim ize the betw een-group 
(data from each point) variation. During the mentioned analysis, the observation of a minim um  of nine 
differentiable clusters w ithin  PCA  spaces w as im plied, w hich corresponds to at least nine different
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assem bly states in the fibril form ation pathway. This approach finally proved to be extrem ely useful 
for determ ining structure-activity relationships [102].
5. Conclusions
In  conclusion, the w ork  presented in this review  show s the enorm ous progress in  the state of 
know ledge concerning am yloid aggregation. Spectroscopic studies of abnorm al protein aggregation 
revealed characteristic m arker bands related to specific secondary structure content occurring at 
successive steps of the aggregation process. The spectroscopic research carried out so far has m ade 
it possible to link  the ratio fluctuations of individual secondary structures content in fibrils w ith  
the occurrence of alternative aggregation pathw ays. In particular, m olecular nanospectroscopy has 
made it possible to study the distribution of particular conform ations along individual amyloid fibrils 
that appeared to have a highly heterogeneous structure at the nanoscale. This trem endous progress 
allow s one to go one step further and conclude about the specific aggregation m echanism  of the 
studied system . Now, the greatest lim itation of nanospectroscopy seem s to be related to technical 
difficulties with transferring measurements into the liquid conditions. The drying process of biological 
com ponents m ay influence their native structure. The efforts of nanospectroscopy com m unity are 
focused on overcoming this lim itation and the progress in this direction had already been presented in 
the w ork of Ram er et al. [72].
The research concerning abnorm al protein aggregation has been  focused so far on studying 
the aggregation of isolated/synthesized peptides and fibrils form ed in vitro. T hat gave one the 
solid benchm ark to study m ore com plicated  system s such as isolated am yloid  plaques from  
neurodegenerative diseases or am yloidosis affected patients. Such w orks have been  lim ited so 
far due to the com plexity  of such system s, bu t now  it seem s to be one of the future directions of 
spectroscopic studies concerning abnorm al protein aggregation.
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